FindTrial
Sign In

Research on the transcriptional regulation to the structural remodeling in atrial fibrillation patients

Research on the transcriptional regulation to the structural remodeling in atrial fibrillation patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-COC-17013241
Enrollment
Unknown
Registered
2017-11-04
Start date
2017-11-01
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

sinus rhythm:none
atrial fibrillation:none

Sponsors

The Fifth Central Hospital of Tianjin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with cardiac valve replacement: electrocardiogram: sinus rhythm or atrial fibrillation.;Inclusion criteria: Patients with cardiac valve replacement: electrocardiogram: sinus rhythm or atrial fibrillation.;Inclusion criteria: Patients with cardiac valve replacement: electrocardiogram: sinus rhythm or atrial fibrillation.;Inclusion criteria: Patients with cardiac valve replacement: electrocardiogram: sinus rhythm or atrial fibrillation.;Inclusion criteria: Patients with cardiac valve replacement: electrocardiogram: sinus rhythm or atrial fibrillation.

Exclusion criteria

Exclusion criteria: patients who have recently taken ACEI or ARB drugs.;Exclusion criteria: patients who have recently taken ACEI or ARB drugs.;Exclusion criteria: patients who have recently taken ACEI or ARB drugs.;Exclusion criteria: patients who have recently taken ACEI or ARB drugs.;Exclusion criteria: patients who have recently taken ACEI or ARB drugs.

Design outcomes

Primary

MeasureTime frame
atrial natriuretic peptide;brain natriuretic peptide;transcription factor MEF-2;—

Countries

China

Contacts

Public ContactZheng Liuying;Zheng Liuying;Zheng Liuying;Zheng Liuying;Zheng Liuying ;;;;

The Fifth Central Hospital of Tianjin;The Fifth Central Hospital of Tianjin;The Fifth Central Hospital of Tianjin;The Fifth Central Hospital of Tianjin;The Fifth Central Hospital of Tianjin

zhengliuyi27@163.com;zhengliuyi27@163.com;zhengliuyi27@163.com;zhengliuyi27@163.com;zhengliuyi27@163.com+86 13920071441;+86 13920071441;+86 13920071441;+86 13920071441;+86 13920071441

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026